InsidersTradesSigma
Track the 셀레믹스 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 셀레믹스 has published 20 public disclosures. Market capitalisation: €104.7bn. The latest transaction was filed on 8 June 2026 (Purchase). Among the most active insiders: 박종갑. All data is accessible without an account.
20
Insider Decl.
n/a
Thresholds
€19m
12 ops.
Buy Volume
€6m
4 ops.
Sell Volume
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,530 of 29,063 companies
27.2
score / 100
Value28
Quality27
FCF yld-2.4%
Earn yld-2.6%
EV/EBITDA·
ROE-37%
Gross mgn50%
Net mgn-70%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 June 2026
Declarations20 total
1,193,602 sharesShareKRXDART:20260608000179
1,193,602 sharesKRXDART:20260608000171
20 of 20 declarations
About 셀레믹스
셀레믹스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the diagnosis and treatment of diseases.